Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Latest filing published 01 Jun 2026 for GLAUKOS Corp. Read the official filing
Filing timeline
BuySaleMark J. Foley
Insider track record
Disclosed buys
2
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark J. Foley: trading record in brief
Filings by Mark J. Foley span 3 companies, the busiest being Revance Therapeutics, Inc., GLAUKOS Corp and Zeltiq Aesthetics Inc. We count 37 filings; the first trade dates from 13 January 2016 and the latest from 28 May 2026.
Market trades split into 2 purchases (€650k) and 4 sales (€1.4M). The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 27 share grants and 2 option exercises.
The latest filing, published on 1 June 2026, reports a share grant in GLAUKOS Corp. The most recent open-market purchase was published on 8 March 2024, 954 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark J. Foley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
1,878 shares0Common StockSEC:0001529196-26-000004:0
1,168 shares0Common StockSEC:0001529196-26-000002:0
864 shares0Common StockSEC:0001415889-25-015178:0
25,000 shares@ US$32.0091.9% of flowCommon StockSEC:0001415889-25-006046:0
996,935 shares@ US$3.6537.5% of flowCommon StockSEC:0000950170-25-015363:0
27,933 shares0Common StockSEC:0000950170-25-014825:0
1,000 shares@ US$2.18450.0% of flowCommon StockSEC:0001479290-25-000004:0
1,000 shares@ US$2.18450.0% of flowCommon StockSEC:0001479290-24-000104:0
1,716 shares0Common StockSEC:0001415889-24-015236:0
3,305 shares@ US$5.3050.2% of flowCommon StockSEC:0001479290-24-000065:0
30,000 shares@ US$6.982.1% of flowCommon StockSEC:0001479290-24-000056:0
Canonical exit: 4 Jun 2024 (T+90)
70,750 shares0Common StockSEC:0001479290-24-000050:0
10,000 shares@ US$7.2758.1% of flowCommon StockSEC:0001415889-24-005327:0
264 shares@ US$7.470.0% of flowCommon StockSEC:0001479290-24-000004:0
122,143 shares0Common StockSEC:0001479290-23-000096:0
26,279 shares@ US$22.57135.8% of flowCommon StockSEC:0001479290-23-000084:0
1,000 shares@ US$15.6060.2% of flowCommon StockSEC:0001479290-23-000081:0
31,279 shares@ US$30.72129.5% of flowCommon StockSEC:0001479290-23-000078:0
3,230 shares0Common StockSEC:0001415889-23-009293:0
175,649 shares0Common StockSEC:0001479290-23-000074:0
5,341 shares@ US$30.651.6% of flowCommon StockSEC:0001479290-23-000042:0
175,649 shares0Common StockSEC:0001479290-23-000034:0
2,948 shares0Common StockSEC:0001415889-23-000386:0
605 shares@ US$12.18050.1% of flowCommon StockSEC:0001479290-23-000001:0
49,274 shares@ US$26.9714.5% of flowCommon StockSEC:0001479290-22-000087:0
25 of 37 declarations
